PFBT
ALT icon

Parkside Financial Bank & Trust’s Altimmune ALT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713 Buy
+235
New +$702 ﹤0.01% 2524
2025
Q3 		– Sell
-105
Closed -$407 – 2716
2025
Q2 		$407 Buy
+105
New +$568 ﹤0.01% 2618

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's ALT Position: Q2 2026 in Review

Parkside Financial Bank & Trust opened a new position in Altimmune (ALT) in Q2 2026: 235 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #2524 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in ALT as recently as Q2 2025.

Parkside Financial Bank & Trust first reported a position in ALT in Q2 2025 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Parkside Financial Bank & Trust held 235 shares of Altimmune worth $713 as of Q2 2026.
  • Altimmune was a new Parkside Financial Bank & Trust position in Q2 2026.
  • Altimmune made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2524 holding.
  • Parkside Financial Bank & Trust first reported a position in Altimmune in Q2 2025 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.